Arden Tissue Bank
https://www.uhcw.nhs.uk/leading-research/about-us/our-facilities/arden-tissue-bank/
Arden Tissue Bank operates under a Human Tissue Authority post mortem licence within a district general hospital. The biobank has generic ethical approval, and is able to collect tissues prospectively across a wide range of tissue types. In addition the biobank has access to the full pathological archive across three hospital sites. The cellular pathology archive is searchable by SNOMED coding for selection of specific conditions of interest. The cellular pathology archive alone totals almost 2 million blocks, with full patient data available from 2005 including pathology reports.
Services
- Access to the full pathology archive
- Digital imaging
- Immunohistochemistry - staining
- Tissue micro array creation
Existing samples:
- Fit and well (finding)
- Malignant tumor of lung (disorder)
Networks
- Confederation of Cancer Biobanks The NCRI’s Confederation of Cancer Biobanks (CCB) is a consortium of biobanks and biosample collections based in the UK, established to encourage greater coordination and promote harmonisation between biobanks – enabling them to share best practice and raise awareness of their collections with researcher
Contact Information
- Email:
- ardentissuebank@uhcw.nhs.uk
- Telephone:
- 02746 967033
- Address:
-
Arden Tissue Bank
Pathology Department
University Hospitals Coventry & Warwick NHS Trust
Binley
Coventry
Warwickshire
CV2 2DX
England
Last Updated: 23/07/2019
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | 9 | 1 | 1 | 8 | 1 | 1 |
| 2016 | 4 | 6 | 1 | 4 | 2 | 1 |
| 2017 | 6 | 5 | 4 | 6 | 6 | 4 |
| 2018 | 11 | 8 | 2 | 11 | 8 | 6 |
| 2019 | 8 | 8 | 5 | 9 | 8 | 4 |
| 2020 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2023 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024 | N/A | N/A | N/A | N/A | N/A | N/A |